Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for Treace Medical Concepts (TMCI) over the last 4 years, with Q3 2025 value amounting to $5000.0.

  • Treace Medical Concepts' Amortizatization of Intangibles fell 9785.41% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $346000.0, marking a year-over-year decrease of 7324.05%. This contributed to the annual value of $1.1 million for FY2024, which is 1856.33% down from last year.
  • Treace Medical Concepts' Amortizatization of Intangibles amounted to $5000.0 in Q3 2025, which was down 9785.41% from $37000.0 recorded in Q2 2025.
  • Treace Medical Concepts' Amortizatization of Intangibles' 5-year high stood at $375000.0 during Q4 2023, with a 5-year trough of $5000.0 in Q3 2025.
  • For the 4-year period, Treace Medical Concepts' Amortizatization of Intangibles averaged around $233000.0, with its median value being $265000.0 (2023).
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first surged by 19761.9% in 2023, then plummeted by 9785.41% in 2025.
  • Treace Medical Concepts' Amortizatization of Intangibles (Quarter) stood at $126000.0 in 2022, then surged by 197.62% to $375000.0 in 2023, then plummeted by 39.47% to $227000.0 in 2024, then plummeted by 97.8% to $5000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $5000.0 for Q3 2025, versus $37000.0 for Q2 2025 and $77000.0 for Q1 2025.